[VRTX] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
02-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 81.44%
YoY- 11.96%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 118,451 351,157 221,700 310,750 328,368 333,994 336,006 -50.12%
PBT -231,654 -340,253 -129,406 -63,511 -442,940 -80,772 -5,112 1174.01%
Tax 803 -155,704 -751 -1,799 -130,313 -2,696 21,355 -88.79%
NP -232,457 44,285 -124,125 -57,165 -308,016 -76,148 -57,543 153.86%
Tax Rate - - - - - - - -
Total Cost 350,908 306,872 345,825 367,915 636,384 410,142 393,549 -7.36%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -196.25 12.61 -55.99 -18.40 -93.80 -22.80 -17.13 408.95%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -1.00 0.19 -0.54 -0.26 -1.43 -0.35 -0.27 139.57%
EPS Diluted -1.00 0.19 -0.54 -0.26 -1.43 -0.35 -0.27 139.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.